Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs Jones Lang LaSalle Inc (JLL) Price & Performance

Elanco Animal Health Incorporated Common StockTrade
Jones Lang LaSalle IncTrade

Price performance (Past 24H)

Key statistics

Elanco Animal Health Incorporated Common Stock vs Jones Lang LaSalle Inc — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.53 (market cap $11.26B), while Jones Lang LaSalle Inc trades at $298.93 (market cap $13.95B). The key difference: Jones Lang LaSalle Inc is the larger of the two by market cap, and Elanco Animal Health Incorporated Common Stock is trading nearer its 52-week high, Jones Lang LaSalle Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and Jones Lang LaSalle Inc for 71 Days on average.

ELANJLL
Market Cap
$11.26B$13.95B
Volume
4,570,386457,462
Sector
HealthReal Estate
52-Week High
$26.84$392.79
52-Week Low
$19.76$280.16
Typical Hold Time
0 Days71 Days
Enterprise Value
$14.65B$16.71B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Elanco Animal Health Incorporated Common Stock

No Aura AI signal available yet.

Jones Lang LaSalle Inc

JLL trades at $296.66, down 2.29% over 24 hours, with a bearish technical signal from moving averages and oscillators. The stock shows strong fundamentals with a P/E of 14.54, P/S of 0.53, and net income margin of 3.64%. Recent earnings have consistently beaten expectations, and cash flow from operations reached $1.19 billion in 2025. Analyst consensus is bullish with a $450.50 price target, supported by positive news on acquisitions and growth prospects.

The outlook for JLL is positive due to robust earnings growth, improving profit margins, and strategic acquisitions. Risks include market volatility, competitive pressures in real estate services, and economic sensitivity. Institutional sentiment remains strong, with a majority of analysts recommending buy. The stock presents a value opportunity if it can sustain its operational momentum amid broader market headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ELAN
100% Buy0% Sell
Avg holding period · 0 Days
JLL

No sentiment data available yet.

About Elanco Animal Health Incorporated Common Stock

Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.

Read more on ELAN →

About Jones Lang LaSalle Inc

Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.

Read more on JLL →